Market Tracker

02/16 5:15pm ET

Advaxis Inc (NASDAQ:ADXS)

2.51
Delayed Data
As of Feb 16
 -0.13 / -4.92%
Today’s Change
2.43
Today|||52-Week Range
10.06
-11.62%
Year-to-Date
No recent news for Advaxis Inc.

Today’s Trading

Previous close2.64
Today’s open2.63
Day’s range2.49 - 2.73
Volume763,024
Average volume (3 months)820,501
Market cap$104.3M
Data as of 4:00pm ET, 02/16/2018

Growth & Valuation

Earnings growth (last year)-11.06%
Earnings growth (this year)-6.28%
Earnings growth (next 5 years)--
Revenue growth (last year)+201.16%
P/E ratioNM
Price/Sales11.45
Price/Book1.91

Competitors

 Today’s
change
Today’s
% change
SNDXSyndax Pharmaceutica...-0.44-4.44%
NERVMinerva Neuroscience...-0.05-0.91%
IMDZImmune Design Corp-0.10-2.90%
URGNUrogen Pharma Ltd-2.16-4.31%
Data as of 4:00pm ET, 02/16/2018

Financials

Next reporting dateMarch 12, 2018
EPS forecast (this quarter)-$0.58
Annual revenue (last year)$12.0M
Annual profit (last year)-$93.4M
Net profit margin-776.62%

Profile

Sector
Health Technology
Industry
Biotechnology
CEO, Chief Business Officer &
Senior VP
Anthony A. Lombardo
Chief Operating Officer &
Senior Vice President
Christopher M. Duke
Corporate headquarters
Princeton, New Jersey

Forecasts